Tradestie Institutional Equity Comparison Engine

VTYX vs IMNM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTYX Overall Edge

VTYX Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VTYX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMNM at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IMNM sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VTYX N/M vs IMNM N/M Fwd P/E
Growth & Margin Winner VTYX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -100.0%
Momentum & Technical Winner VTYX
1Y +786.1% vs +6.7% ยท 52W Pos 55% vs 11%
Options & Structure Winner VTYX
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (7th %ile IV)
VTYX NASDAQ
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
1M Return +0.36%
1Y Return +786.08%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0
IMNM NASDAQ
Immunome, Inc.
Pharmaceutical Preparations
$17.61
-6.18% 1D
Market Cap $2.2B
1M Return +6.92%
1Y Return +6.66%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VTYX +786.08% IMNM +6.66% Spread: +16.13 pp (VTYX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VTYX TTM Op. Margin: 0.0% IMNM TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTYX vs IMNM. Trailing 12-month operating profitability (VTYX 0.0% vs IMNM 0.0%) and valuation multiples (VTYX N/M vs IMNM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VTYX (5) vs IMNM (1)
Institutional Metric VTYX IMNM Criterion Row Winner
Market Capitalization Scale $1.0B $2.2B Larger Scale IMNM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -100.0% Higher Growth VTYX
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -45.4% -78.7% Higher ROE VTYX
52-Week Range Position Momentum 55% ($1โ€“$25) 11% ($16โ€“$30) Stronger Trend VTYX
Beta / 30D Volatility Risk Regime 2.07ฮฒ ยท 2% Vol 1.53ฮฒ ยท 62% Vol Lower Realized Risk VTYX
Unified Institutional Score Composite Signal 50.4 / 100 (HOLD) 41.1 / 100 (SELL) Higher Composite VTYX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VTYX vs IMNM Buy Guide
VTYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VTYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMNM BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live IMNM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VTYX nor IMNM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.